NPTX2 and Cerebral cortical atrophy: This is supported by the finding that reduced CSF NPTX2 levels were associated with increased cortical atrophy and reduced glucose metabolism in temporal and parietal regions of the brain, regions that are particularly susceptible to AD pathology.